Tunneled-cuffed catheter associated infections in hemodialysis patients who are seropositive for the human immunodeficiency virus

Journal of the American Society of Nephrology

Volumn 11, Issue 11, 2000, Pages 2122-2127

  Mokrzycki, Michele H ^a,b,c   Schröppel, Bernd ^a,b   Von Gersdorff, Gero ^a,b   Rush, Heather ^a,c   Zdunek, Miroslaw P ^a,c   Feingold, Robert ^a,c  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b JACOBI MEDICAL CENTER   (United States)

^c MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BACTEREMIA; BACTERICIDAL ACTIVITY; CATHETER INFECTION; DISEASE ASSOCIATION; FEMALE; HELPER CELL; HEMODIALYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RATE; LYMPHOCYTE FUNCTION; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL CHEMOTAXIS; PREDICTION; PRIORITY JOURNAL; SEROCONVERSION; VASCULAR ACCESS;

EID: 0033760119     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. NKF-DOQI clinical practical guidelines for vascular access: National Kidney Foundation-Dialysis Outcomes Quality Initiative. Am J Kidney Dis 30[Suppl 3]: S150-S191, 1997
2. United States Renal Data System: USRDS 1996 Annual Data Report. The USRDS Dialysis Morbidity and Mortality Study (Wave 2). Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Disease, 1996
3. Dryden MS, Samson A, Ludlam HA, Wing AJ, Phillips I: Infective complications associated with the use of Quinton "Permcath" for long-term central vascular access in haemodialysis. J Hasp Infect 19: 257-262, 1991
4. Moss AH, Vasilakis C, Holley JL, Foulks CJ, Pillai K, McDowell DE: Use of a silicone dual-lumen catheter with a Dacron cuff as a long-term vascular access for hemodialysis patients. Am J Kidney Dis 16: 211-215, 1990
5. Marr KA, Sexton DJ, Conlon PJ, Corey R, Schwab SJ, Kirkland KB: Catheter-related bacteremia and outcome of attempted catheter salvage in patients undergoing hemodialysis. Ann Intern Med 127: 275-280, 1997
6. Keane WF, Shapiro FL, Raij L: Incidence and type of infections occurring in 445 chronic hemodialysis patients. Trans Am Soc Artif Intern Organs 23: 41-47, 1977
7. Flo RW, Naess A, Nilsen A, Harthung S, Solberg CO: A longitudinal study of phagocyte function in HIV-infected patients. AIDS 8: 771-777, 1994
8. Beathard GA: Management of bacteremia associated with tunneled-cuffed hemodialysis catheters. J Am Soc Nephrol 10: 1045-1049, 1999
9. Pereira BJG, Levey AS: Hepatitis C virus infection in dialysis and transplantation. Kidney Int 51: 981-999, 1997
10. Jaar BG, Hermann JA, Furth SL, Briggs W, Powe NR. Septicemia in diabetic hemodialysis patients: Comparison of incidence, risk factors, and mortality with nondiabetic hemodialysis patients. Am J Kidney Dis 35: 282-292, 2000
11. Hoen B, Paul-Dauphin A, Hestin D, Kessler M. EPICIDAL: A multicenter prospective study of risk factors for bacteremia in chronic hemodialysis patients. J Am Soc Nephrol 9: 869-876, 1998
12. Powe NR, Jaar B, Furth SL, Hermann J, Briggs W: Septicemia in dialysis patients: Incidence, risk factors, and prognosis. Kidney Int 55: 1081-1090, 1999
13. McLaughlin K, Jones B, Mactier R, Porteus C: Long-term vascular access for hemodialysis using silicon dual-lumen catheters with guidewire replacement of catheters for technique salvage. Am J Kidney Dis 29: 553-559, 1997
14. Henry K, Thurn JR, Johnson S: Experience with central venous catheters in patients with AIDS. N Engl J Med 320: 1496, 1989
15. Saltzman BR, Perlman DC, Levy DI, et al.: Infections and complications of indwelling central venous catheters (CVC): Comparisons between patients with AIDS vs other illnesses (non-AIDS).
16. Raviglione MC, Battan R, Pablos-Mendez A, Aceves-Casillas P, Mullen MP, Taranta A: Infections associated with Hickman catheters in patients with acquired immunodeficiency syndrome. Am J Med 86: 780-786, 1989
17. Skoutelis AR, Murphy RL, MacDonell KB, VonRoenn JH, Sterkel CD, Phair JP: Indwelling central venous catheter infections in patients with acquired immune deficiency syndrome. J Acquir Immune Defic Syndr 3: 335-342, 1990
18. Powe NR, Jaar B, Furth SL, Hermann J, Briggs W: Septicemia in dialysis patients: Incidence, risk factors, and prognosis. Kidney Int 55: 1081-1090, 1999
19. Roilides E, Marshall D, Venzon D, Butler K, Husson R, Pizzo PA: Bacterial infections in human immunodeficiency virus type 1 infected catheters and antiretroviral agents. Pediatr Infect Dis J 10: 813-819, 1991
20. Fichtenbaum CJ, Dunagan C, Powderly WG: Bacteremia in hospitalized patients infected with the human immunodeficiency virus: A case-control study of risk factors and outcome. J Acquir Immune Defic Syndr Human Retrovirol 8: 51-57, 1995
21. Robinson D, Suhocki P, Schwab SJ: Treatment of infected tunneled venous access hemodialysis catheters with guidewire exchange. Kidney Int 53: 1792-1794, 1998
22. Dressier R, Peters AT, Lynn RI: Pseudomonal and candidal peritonitis as a complication of continuous ambulatory peritoneal dialysis in human immunodeficiency virus-infected patients. Am J Med 86: 787-790, 1989
23. Schaffer D: Catheter-related sepsis complicating long-term, tunnelled central venous dialysis catheters: Management by guide-wire exchange. Am J Kidney Dis 25: 593-596, 1995